Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $3.21 billion. The enterprise value is $2.72 billion.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 109.84 million shares outstanding. The number of shares has increased by 4.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 109.84M |
| Shares Change (YoY) | +4.86% |
| Shares Change (QoQ) | +5.26% |
| Owned by Insiders (%) | 1.39% |
| Owned by Institutions (%) | 79.97% |
| Float | 100.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.08 |
| Forward PS | 24.74 |
| PB Ratio | 3.90 |
| P/TBV Ratio | 4.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.26 |
| Quick Ratio | 2.64 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -80.56 |
Financial Efficiency
Return on equity (ROE) is -32.05% and return on invested capital (ROIC) is -18.33%.
| Return on Equity (ROE) | -32.05% |
| Return on Assets (ROA) | -15.50% |
| Return on Invested Capital (ROIC) | -18.33% |
| Return on Capital Employed (ROCE) | -31.41% |
| Revenue Per Employee | $223,823 |
| Profits Per Employee | -$134,869 |
| Employee Count | 1,869 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 8.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.09% in the last 52 weeks. The beta is 1.04, so Zai Lab's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +78.09% |
| 50-Day Moving Average | 33.10 |
| 200-Day Moving Average | 27.05 |
| Relative Strength Index (RSI) | 43.80 |
| Average Volume (20 Days) | 1,183,875 |
Short Selling Information
| Short Interest | 7.77M |
| Short Previous Month | 7.32M |
| Short % of Shares Out | 8.07% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, Zai Lab had revenue of $418.33 million and -$252.07 million in losses. Loss per share was -$2.48.
| Revenue | 418.33M |
| Gross Profit | 30.93M |
| Operating Income | -268.12M |
| Pretax Income | -298.33M |
| Net Income | -252.07M |
| EBITDA | -255.82M |
| EBIT | -268.12M |
| Loss Per Share | -$2.48 |
Full Income StatementBalance Sheet
The company has $757.26 million in cash and $192.30 million in debt, giving a net cash position of $564.97 million or $5.14 per share.
| Cash & Cash Equivalents | 757.26M |
| Total Debt | 192.30M |
| Net Cash | 564.97M |
| Net Cash Per Share | $5.14 |
| Equity (Book Value) | 810.75M |
| Book Value Per Share | 7.48 |
| Working Capital | 722.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$186.46 million and capital expenditures -$6.22 million, giving a free cash flow of -$192.68 million.
| Operating Cash Flow | -186.46M |
| Capital Expenditures | -6.22M |
| Free Cash Flow | -192.68M |
| FCF Per Share | -$1.75 |
Full Cash Flow StatementMargins
Gross margin is 7.39%, with operating and profit margins of -64.09% and -60.26%.
| Gross Margin | 7.39% |
| Operating Margin | -64.09% |
| Pretax Margin | -60.26% |
| Profit Margin | -60.26% |
| EBITDA Margin | -61.15% |
| EBIT Margin | -64.09% |
| FCF Margin | n/a |